NCT01871727 2024-11-13A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell LymphomaEisai Inc.Phase 3 Completed112 enrolled 40 charts
NCT01728805 2024-04-25Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCLKyowa Kirin Co., Ltd.Phase 3 Completed372 enrolled 14 charts 1 FDA
NCT02811783 2022-10-28Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCLElorac, Inc.Phase 3 Terminated59 enrolled
NCT02448381 2022-04-15FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)SoligenixPhase 3 Completed169 enrolled 13 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT00127881 2012-07-26Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary SyndromeEmergent Product Development Seattle LLCPhase 3 Terminated76 enrolled